To include your compound in the COVID-19 Resource Center, submit it here.

Helix, Moffitt explore data extraction and checkpoint inhibitors with L-DOS47

H. Lee Moffitt Cancer Center and Research Institute (Tampa, Fla.) and Helix BioPharma Corp

Read the full 147 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE